Clinical Trials Sponsored by NIPRO

Total 7 results

Nipro Europe N.V.

Completed

In Vivo Evaluation of the Nipro Elisio™ Dialyzer

Chronic Kidney Disease

France
EXcorLab GmbH
Nipro Europe N.V.

Completed

Test of the Nipro ELISIO H Dialyzer in Different Dialysis Treatment Procedures

Chronic Kidney Disease

Belgium
Universitaire Ziekenhuizen KU Leuven
NIPRO

Completed

Strategies for Asymmetrical Triacetate Dialyzer Heparin-Free Effective Hemodialysis (SAFE)

Hemodialysis Complication

Belgium
University Hospital, Ghent
Nissho Nipro Europe

Completed

Uremic Toxin Removal With a New High Flux Cellulose Triacetate Membrane

Haemodialysis

Belgium
UConn Health
Dialysis Clinic, Inc.; Nipro Medical Corporation

Completed

Potential Effect of Dialyzer Leaching of BPA From the Fresenius Optiflux 160NR Compared to the Nipro ELISIO-15H (bisphenol-A)

End Stage Renal Disease
University of Missouri-Columbia
Dialysis Clinic, Inc.; Nipro Medical Corporation

Completed

A Clinical Study Comparing Basic Performance and Hemocompatibility of 3 Different Dialyzers in Hemodialysis Patients

End Stage Renal Disease (ESRD)

United States
Oles Honchar Dnipro National University
SynthezAI Corp.

Recruiting

Study of the Effect of the Auditory Stimulation on Stuttering Symptoms in Patients With a Deficit of Spectral Power in the EEG Beta Frequency Band (ZOV)

Stuttering, Adult | Stammering

Ukraine

3

Subscribe